BR9709432A - Composto antivirais - Google Patents

Composto antivirais

Info

Publication number: BR9709432A
Authority: BR; Brazil
Prior art keywords: antiviral compounds; antiviral; compounds
Prior art date: 1996-06-06

Application number

BR9709432A

Other languages

English (en)

Inventor

Louis Nickolaus Jungheim

Shawn Christpher Miller

Wayne Alfred Sptzer

Mark Joseph Tebbe

Frantz Victor

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-06

Filing date

1997-06-05

Publication date

1999-08-10

1997-06-05 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1999-08-10 Publication of BR9709432A publication Critical patent/BR9709432A/pt

Links

230000000840 anti-viral effect Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

BR9709432A 1996-06-06 1997-06-05 Composto antivirais BR9709432A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1922496P	1996-06-06	1996-06-06
PCT/US1997/008846 WO1997046235A1 (en)	1996-06-06	1997-06-05	Anti-viral compounds

Publications (1)

Publication Number	Publication Date
BR9709432A true BR9709432A (pt)	1999-08-10

Family

ID=21792091

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9709432A BR9709432A (pt)	1996-06-06	1997-06-05	Composto antivirais

Country Status (10)

Country	Link
US (1)	US5821242A (pt)
EP (1)	EP0938310A4 (pt)
JP (1)	JP2001502661A (pt)
KR (1)	KR20000016405A (pt)
CN (1)	CN1220603A (pt)
AU (1)	AU3286297A (pt)
BR (1)	BR9709432A (pt)
CA (1)	CA2254993A1 (pt)
EA (1)	EA001389B1 (pt)
WO (1)	WO1997046235A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5891874A (en) *	1996-06-05	1999-04-06	Eli Lilly And Company	Anti-viral compound
AU6031898A (en) *	1997-01-22	1998-08-07	Eli Lilly And Company	Anti-viral compounds
ATE238998T1 (de)	1997-02-25	2003-05-15	Us Gov Health & Human Serv	Substituierte benzimidazole als nicht-nucleoside reverse transcriptase inhibitore
AU7715198A (en) *	1997-06-04	1998-12-21	Eli Lilly And Company	Anti-viral compounds
KR20010025055A (ko) *	1998-05-20	2001-03-26	피터 지. 스트링거	항바이러스 화합물
EP1107961A4 (en)	1998-08-25	2002-01-30	Univ Yale	INHIBITION AND TREATMENT OF HEPATITIS B VIRUS AND FLAVIVIRUS WITH HELIOXANTHIN AND ITS ANALOGS
BRPI0407374A (pt)	2003-02-19	2006-01-10	Univ Yale	Análogos de nucleosìdeo antiviral e métodos para tratar infecções virais, especialmente infecções de hiv
US7754718B2 (en)	2004-05-05	2010-07-13	Yale University	Antiviral helioxanthin analogs
MX2010013019A (es) *	2008-05-27	2011-03-21	Biota Scient Management Pty Ltd	Sales antivirales.
CA2813179A1 (en) *	2010-09-30	2012-04-05	Boehringer Ingelheim International Gmbh	Solid state forms of a potent hcv inhibitor
US9487476B2 (en)	2011-10-12	2016-11-08	Yale University	Catechol diethers as potent anti-HIV agents
WO2017181317A1 (en) *	2016-04-18	2017-10-26	Eli Lilly And Company	Treatment for nonalcoholic steatohepatitis and fibrosis
CN109265504B (zh) *	2018-11-08	2021-07-02	河南省科学院高新技术研究中心	4-氨基酸取代嘧啶核苷化合物及其药物用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4289782A (en) *	1979-04-17	1981-09-15	Eli Lilly And Company	Antiviral 1-sulfonylbenzimidazoles
US4401817A (en) *	1981-04-20	1983-08-30	Eli Lilly And Company	Carbonyl-substituted 1-sulfonylbenzimidazoles
US4420479A (en) *	1982-04-08	1983-12-13	Eli Lilly And Company	Olefinic benzimidazoles, formulations, and antiviral methods
US4434288A (en) *	1982-04-08	1984-02-28	Eli Lilly And Company	Preparation of substituted 1-thiazinyl or 1-thiazolyl-2-aminobenzimidazoles
US4492708A (en) *	1982-09-27	1985-01-08	Eli Lilly And Company	Antiviral benzimidazoles
JPS58188868A (ja) *	1983-04-08	1983-11-04	イ−ライ・リリ−・アンド・カンパニ−	オレフイン系ベンズイミダゾ−ル類
US5216003A (en) *	1992-01-02	1993-06-01	G. D. Searle & Co.	Diacid-containing benzimidazole compounds for treatment of neurotoxic injury
US5545653A (en) *	1995-06-07	1996-08-13	Eli Lilly And Company	Anti-viral compounds
US5891874A (en) *	1996-06-05	1999-04-06	Eli Lilly And Company	Anti-viral compound
JP2000511899A (ja) *	1996-06-05	2000-09-12	イーライ・リリー・アンド・カンパニー	抗―ウイルス性化合物群

1997
- 1997-06-04 US US08/868,638 patent/US5821242A/en not_active Expired - Fee Related
- 1997-06-05 CA CA002254993A patent/CA2254993A1/en not_active Abandoned
- 1997-06-05 CN CN97195112A patent/CN1220603A/zh active Pending
- 1997-06-05 EP EP97928660A patent/EP0938310A4/en not_active Withdrawn
- 1997-06-05 BR BR9709432A patent/BR9709432A/pt not_active Application Discontinuation
- 1997-06-05 KR KR1019980709979A patent/KR20000016405A/ko not_active Withdrawn
- 1997-06-05 JP JP10500628A patent/JP2001502661A/ja active Pending
- 1997-06-05 AU AU32862/97A patent/AU3286297A/en not_active Abandoned
- 1997-06-05 EA EA199900003A patent/EA001389B1/ru not_active IP Right Cessation
- 1997-06-05 WO PCT/US1997/008846 patent/WO1997046235A1/en not_active Ceased

Also Published As

Publication number	Publication date
EP0938310A1 (en)	1999-09-01
CN1220603A (zh)	1999-06-23
EP0938310A4 (en)	2001-03-21
EA001389B1 (ru)	2001-02-26
CA2254993A1 (en)	1997-12-11
EA199900003A1 (ru)	1999-06-24
KR20000016405A (ko)	2000-03-25
AU3286297A (en)	1998-01-05
US5821242A (en)	1998-10-13
WO1997046235A1 (en)	1997-12-11
JP2001502661A (ja)	2001-02-27

Legal Events

Date	Code	Title	Description
2004-09-28	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2005-03-08	B09B	Patent application refused [chapter 9.2 patent gazette]

Publication	Publication Date	Title
BR9709643A (pt)	1999-08-10	Compostos antivirais
ID19403A (id)	1998-07-09	Senyawa-senyawa heterosiklik
ID19609A (id)	1998-07-23	Senyawa-senyawa heterosiklik
ID16152A (id)	1997-09-04	Senyawa-senyawa triaril
ID15904A (id)	1997-08-14	Senyawa-senyawa tiofenopirimidina
PT860428E (pt)	2005-04-29	Compostos pirimidiona
IS5479A (is)	2000-05-03	Efnasambönd
IS5478A (is)	2000-05-03	Efnasambönd
IS5477A (is)	2000-05-03	Efnasambönd
ID22850A (id)	1999-12-09	Senyawa-senyawa pirazina
NO994877D0 (no)	1999-10-07	Kalsilytiske forbindelser
BR9710352A (pt)	1999-08-17	Compostos piridilpirrole
ID18685A (id)	1998-04-30	Senyawa trisiklik tersubstitusi
ID20323A (id)	1998-11-26	Senyawa-senyawa triazinilaminostilbena
DE69716924D1 (de)	2002-12-12	Phosphonat-nukleotid-verbindungen
IS5208A (is)	1999-10-05	Efnasambönd
NO20005795D0 (no)	2000-11-16	Antivirale forbindelser
BR9705635A (pt)	1999-05-18	Compostos
ID19490A (id)	1998-07-16	Kombinasi-kombinasi antiviral
DK0923594T3 (da)	2003-02-10	Bromotiacumicinforbindelser
FI970151L (fi)	1997-01-14	Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
BR9709528A (pt)	1999-08-10	Compostos antivirais
IS5237A (is)	1999-11-01	Efnasambönd
DE69709659D1 (de)	2002-02-21	Halopropargyl-einschlussverbindungen
EE9900602A (et)	2000-08-15	Ühendid